My time has come, and I'm on my way Through it all I made it clear today, yeah

And I can't wait to see you once again

Welcome back to part 2 of this episode on Pfizer's new model valent vaccine

Okay, so I went to Pfizer's website, right?

To discuss their press release that was Friday June 23rd, 2023

Talking about the new vaccine, okay? So this is a monovalent COVID-19 vaccine

Pfizer and biotech, who are working together on this, submit applications to US, FDA, for the Omnicron XBB 1.5, monovalent vaccine

June 23rd, we are now in September and that variant is already almost phased out completely

But in from the Pfizer's website directly, here are the things I found interesting

The Omnicron sub lineages, so everything coming from Omnicron currently accounts for nearly all of COVID cases in the US

Says we're not seeing really basically anything from the original SARS-CoV-2 variants, not seeing anything from Delta

Everything is coming from Omnicron and specifically they say everything is coming from Omnicron XBB

This is why they're saying this so that they say your other vaccines not going to work for you anymore

That's what they're saying. We're already on to a new one and your other coverage doesn't count

Even though we promised it would count, it doesn't count anymore

And it says the companies have, so this is again just Pfizer, Pfizer and biotech working together

So we'll just, for the sake of ease, I'll just say Pfizer

Pfizer's manufactured this new vaccine to ensure readiness ahead of the fall and winter season

Okay, so this is like, oh, we see an opportunity here

Now they skipped a year though, so you see the first initial vaccines came out with the very end of 2020 but mostly 2021

They didn't want to have a new version for 2022 because everybody would have really caught on that this was going to be an annual thing

They gave some space to make it look like everybody did their thing and now we're going back to life

...